Navigation Links
Spectrum Announces Uni-Onward as its Taiwanese Distributor
Date:5/19/2010

Spectrum Chemical Mfg. Corp. has appointed Uni-Onward as its new distribution partner for the Taiwanese market. Uni-Onward's recent focus on USP/NF grade chemicals is directly aligned with Spectrum's comprehensive product line of monograph material. Uni-Onward is a premier lab chemicals distributor in Taiwan and has built an outstanding reputation since its establishment in 1987.

New Brunswick, NJ (PRWEB) May 19, 2010 -- Spectrum Chemical Mfg. Corp. (www.SpectrumChemical.com) announces Uni-Onward Corp. as its new distribution partner in Taiwan. Since its inception in 1987, Uni-Onward has become one of the largest distributors in Taiwan with a product offering of over 30,000 chemical reagents. A modern distribution center located in Taipei provides storage for toxic, corrosive, flammable, and low temperature items. Uni-Onward has a strong focus on customer service and provides its customers with an online portal where they can check product availability, lead time, and pricing. "I was very impressed by Uni-Onwards professionalism during my visit with them. Uni-Onward shares Spectrum's focus on quality products and customer service and will help Spectrum grow in the Asia Pacific market," says Marc Hayem, Spectrum's CEO.

About Uni-Onward Corp.

Founded in 1987, Uni-Onward is now Taiwan's leading supplier of biochemical reagents and chemical products. The core business includes distribution of reagents for multiple uses in the following industries: Government institutions, schools, optical and electrical materials and various commercial industries. With the capability of providing over 200,000 types of chemical and biochemical testing products, Uni-Onward with 158 employees currently delivers service to approximately 30% of the research institutes, R&D chemical products and fine chemistry market.


About Spectrum Chemical Mfg. Corp.
Founded in 1971, Spectrum Chemical Mfg. Corp. manufactures and distributes fine chemicals in laboratory and production quantities. Spectrum's chemical offering consists of over 15,000 active pharmaceutical ingredients (API's), excipients, biochemicals, nutraceuticals, cosmetic ingredients, analytical reagents, and chemical solutions. Spectrum's ISO 9001:2008 certified facilities are FDA registered and operate under current Good Manufacturing Practices (cGMP). To learn more about Spectrum visit www.SpectrumChemical.com

# # #

Read the full story at http://www.prweb.com/releases/2010/05/prweb4010634.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
3. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
4. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
5. Energetiqs Laser-Driven Light Source Technology Enables Continuous Spectrum Light Sources, from Visible to Deep Ultraviolet
6. Spectrum Blue Steel's fresh foreign investment at 18 Billion and the Biosphere process spark attention on a global scale
7. "Brave New Reality" Provides a Wide Spectrum of High Tech News and Easy Science.
8. Geecf: Spectrum Blue Steel Announces Strategic Partnership with Al Manhal International Group of Abu Dhabi to Deploy Biosphere Facilities
9. GEECF: Spectrum Launches Zero Waste Philippines and Gears Towards Cheap Green Energy
10. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
11. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Spectrum Announces Uni-Onward as its Taiwanese Distributor 
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
(Date:1/21/2017)... CAMBRIDGE, Mass. , Jan. 21, 2017   ... of novel compounds designed to target cancer stemness pathways, ... lead investigational compound, napabucasin, at the 2017 American Society ... San Francisco . In ... administered investigational agent designed to inhibit cancer stemness pathways ...
(Date:1/20/2017)... , Jan. 20, 2017 Ginkgo ... of Gen9, a pioneer in the synthesis and ... unique expertise in assembling pathway-length synthetic DNA into ... and capacity in the construction of new organism ... industries. "Gen9 was founded to significantly ...
(Date:1/19/2017)... 2017 Research and Markets has announced the ... Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... market is projected to reach $15,737 million by 2022 from $6,521 ... 2022. Omic technologies segment accounted for more than ...
Breaking Biology Technology:
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at ... possibilities for graphene by combining the material with ... highly sensitive pressure detector able to sense pulse, ... a small spider.  The research ... can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/8/2016)... 8, 2016  Singulex, Inc., the leader in Next ... into a license and supply agreement with Thermo Fisher ... provides Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), ... is used to diagnose systemic bacterial infection and sepsis ... to aid in assessing the risk of critically ill ...
(Date:12/7/2016)... , December 7, 2016 BioCatch , ... expansion of its patent portfolio, which grew to over 40 granted and ... , , ... recently filed patent entitled " System, Device, and Method Estimating ... that enables device makers to forego costly hardware components needed to estimate ...
Breaking Biology News(10 mins):